TABLE II.

Time to treatment and treatment type in 109 patients at point of data capture

Variable	Value
Dx to start of first-line drug therapy (days)
Median	49
IQR	24–131
End of 1st-line drug therapy to start of 2nd-line drug therapy (days)
Median	49
IQR	19–149
Start of 1st-line platinum-based drug therapy to start of 2nd-line drug therapy (days)
Median	55
IQR	20–146
Line of drug treatment at point of data capture [n (%)]
First	56 (51)
Second	46 (42)
Third	7 (6)
Use of non-drug treatmentsa [n (%)]
Surgery	35 (32)
Radiotherapy	82 (75)
Neither	13 (12)

^aBefore initiation of drug treatment; patients might previously have received surgery or radiotherapy, or both.

Dx = diagnosis; IQR = interquartile range.